20 May 2025 | 3 – 4 pm CEST
Zoom Registration
Speaker: David Bendetowicz
CHU – Reference Center for Rare Multiple System Atrophy, University Hospital Bordeaux, France
Domain: Treatment/Therapy
DBS in Dystonia – the network perspective
Genetic therapies and therapy developments for rare movement disorders
State of the art of clinical stage gene therapies for Leukodystrophies
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Advanced therapies and clinical trials in Leukodystrophies
Haematopoietic Stem Cell Transplantation in Leukodystrophies
Non-pharmacological approaches to treatment in svPPA
Towards precision medicine in NBIA
DBS in Dystonia – Targets, programming and therapeutic challenges
Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
27 Sep. 2022
Speaker: Daniel Weiß
Hertie Institute for Clinical Brain Research, University of Tübingen, Germany
The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’
5 Apr. 2022
Speaker: Robert Rusina & Zsolt Cséfalvay
Thomayer Hospital, Prague, Czech Republic; Comenius University in Bratislava, Slovakia
Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide
ASO RNA splice modulating therapies for genetic brain disorders
Anti-spastic therapies in Hereditary Spastic Paraplegia
11 Jan. 2022
Speaker: Marcondes C. França Jr.
School of Medical Sciences, University Campinas (UNICAMP), Brasil
Deep brain stimulation in children with acquired dystonia
Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
X-Linked leukodystrophies – Update
Adult leukodystrophies/early symptoms of late-onset Leukodystrophies
Treatable dystonia &dystonia in inborn errors of metabolism
Genetic forms of parkinson
Metachromatic Leukodystrophy – update
15 Jun. 2021
Speaker: Samuel Gröschel & Ingeborg Krägeloh
University Hospital Tübingen, Germany
Better Conversations – Communication Partner Training for language led dementias
18 May 2021
Speaker: Kathryn Peall
Neurosciences and Mental Health Research Institute, Cardiff, United Kingdom
Gene therapy in neuromuscular and mitochondrial disorders
Challenges in Frontotemporal Dementia: clinical, genetic and pathological heterogeneity
23 Mar. 2021
Speaker: Harro Seelaar
Erasmus University Medical Center, Rotterdam, Netherlands